Docusign (NASDAQ:DOCU) Price Target Cut to $60.00 by Analysts at Wells Fargo & Company

Docusign (NASDAQ:DOCUFree Report) had its target price decreased by Wells Fargo & Company from $75.00 to $60.00 in a report released on Wednesday,Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the stock.

Several other research analysts have also weighed in on DOCU. HSBC set a $53.00 price objective on shares of Docusign in a report on Friday, February 13th. Needham & Company LLC restated a “hold” rating on shares of Docusign in a research note on Tuesday, March 10th. Citigroup reaffirmed a “market outperform” rating on shares of Docusign in a research report on Monday, March 2nd. Cantor Fitzgerald reiterated an “outperform” rating on shares of Docusign in a research note on Wednesday, December 17th. Finally, Bank of America lowered their price objective on Docusign from $102.00 to $82.00 and set a “neutral” rating for the company in a report on Friday, December 5th. Five analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $66.67.

Check Out Our Latest Stock Analysis on Docusign

Docusign Stock Up 2.9%

Shares of DOCU opened at $48.90 on Wednesday. The business’s 50 day moving average is $50.69 and its two-hundred day moving average is $64.35. Docusign has a 52-week low of $40.16 and a 52-week high of $94.67. The firm has a market cap of $9.79 billion, a price-to-earnings ratio of 33.04, a PEG ratio of 2.07 and a beta of 1.03.

Docusign (NASDAQ:DOCUGet Free Report) last released its quarterly earnings results on Tuesday, March 17th. The company reported $1.01 earnings per share for the quarter, topping analysts’ consensus estimates of $0.95 by $0.06. The business had revenue of $836.86 million during the quarter, compared to the consensus estimate of $828.23 million. Docusign had a net margin of 9.60% and a return on equity of 16.70%. The business’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same quarter last year, the company earned $0.86 earnings per share. On average, equities analysts expect that Docusign will post 1.17 earnings per share for the current fiscal year.

Docusign announced that its board has authorized a stock repurchase plan on Tuesday, March 17th that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the company to reacquire up to 21% of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s board of directors believes its shares are undervalued.

Insider Buying and Selling at Docusign

In related news, insider James P. Shaughnessy sold 12,000 shares of the business’s stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $67.03, for a total transaction of $804,360.00. Following the completion of the sale, the insider owned 54,550 shares of the company’s stock, valued at $3,656,486.50. This represents a 18.03% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Allan C. Thygesen sold 26,250 shares of the stock in a transaction dated Friday, January 9th. The stock was sold at an average price of $69.60, for a total transaction of $1,827,000.00. Following the sale, the chief executive officer owned 142,261 shares in the company, valued at approximately $9,901,365.60. This trade represents a 15.58% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 51,477 shares of company stock valued at $3,521,607 over the last three months. 1.01% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Docusign

A number of hedge funds and other institutional investors have recently bought and sold shares of DOCU. Norges Bank bought a new position in shares of Docusign during the fourth quarter valued at approximately $186,795,000. Capital World Investors lifted its holdings in shares of Docusign by 38.1% in the 4th quarter. Capital World Investors now owns 5,815,804 shares of the company’s stock worth $397,801,000 after purchasing an additional 1,603,900 shares during the last quarter. Woodline Partners LP boosted its position in Docusign by 24,412.7% during the 3rd quarter. Woodline Partners LP now owns 958,938 shares of the company’s stock valued at $69,130,000 after purchasing an additional 955,026 shares during the period. Arrowstreet Capital Limited Partnership boosted its position in Docusign by 46.1% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 3,001,132 shares of the company’s stock valued at $205,277,000 after purchasing an additional 946,512 shares during the period. Finally, Marshall Wace LLP grew its stake in Docusign by 1,575.5% during the 4th quarter. Marshall Wace LLP now owns 888,411 shares of the company’s stock worth $60,767,000 after buying an additional 835,388 shares during the last quarter. 77.64% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Docusign

Here are the key news stories impacting Docusign this week:

  • Positive Sentiment: Q4 results and FY27 outlook beat estimates — DocuSign reported adjusted EPS of $1.01 and revenue of $836.9M, topping Street forecasts and signaling continued subscription growth and momentum into fiscal 2027. Docusign’s Q4 Earnings and Revenues Surpass Estimates, Increase Y/Y
  • Positive Sentiment: Share‑repurchase boost — Management authorized a $2.0 billion increase to the buyback program, a direct capital‑return action that supports EPS and signals confidence from the board. PR Newswire: Share Repurchase Increase
  • Positive Sentiment: Product traction in IAM and AI — Management highlighted strong IAM ARR (> $350M after 18 months) and plans to grow IAM share and AI partnerships, supporting secular expansion beyond e‑signatures. Seeking Alpha: IAM ARR and AI Partnerships
  • Neutral Sentiment: Analysts and investors want higher top‑line acceleration — Coverage notes that while results showed traction, many want to see sustained >10% revenue growth before committing, leaving some investors on the sidelines. MSN: Analysts Wait for 10%+ Revenue Growth
  • Neutral Sentiment: Some buy ratings remain — BTIG reaffirmed a buy with a $70 target, showing pockets of analyst optimism despite broad caution. Benzinga: BTIG Reaffirms Buy
  • Negative Sentiment: Broad downward revisions to price targets — Multiple firms (Citigroup, Morgan Stanley, JPMorgan, UBS, Wells Fargo, RBC, Piper Sandler, Baird, others) cut targets after the print, reflecting concerns about growth runway and execution; that pressure caps upside even with the beat. Blockonomi: Analyst Targets Slashed TickerReport: Citigroup Cut
  • Negative Sentiment: Valuation and growth trade‑offs highlighted — Analysts trimmed fair‑value estimates and flagged pricing/AI competition risks, underscoring why some investors remain cautious despite product progress. Yahoo Finance: Valuation and AI Risks

About Docusign

(Get Free Report)

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.

Read More

Analyst Recommendations for Docusign (NASDAQ:DOCU)

Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.